47
Views
34
CrossRef citations to date
0
Altmetric
Review

Breast cancer biomarkers and molecular medicine: part II

, , , , , , , & show all
Pages 169-188 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rachel Suter & James A Marcum. (2007) The molecular genetics of breast cancer and targeted therapy. Biologics: Targets and Therapy 1:3, pages 241-258.
Read now

Articles from other publishers (32)

David Wang. 2019. Functional Proteomics. Functional Proteomics 69 81 .
Gookjoo Jeong, Hansol Bae, Dawoon Jeong, Juyeon Ham, Sungbin Park, Hyeon Woo Kim, Han-Sung Kang & Sun Jung Kim. (2018) A Kelch domain-containing KLHDC7B and a long non-coding RNA ST8SIA6-AS1 act oppositely on breast cancer cell proliferation via the interferon signaling pathway. Scientific Reports 8:1.
Crossref
Ishita Gupta, Ikram Burney, Mansour S. Al-Moundhri & Yahya Tamimi. (2017) Molecular genetics complexity impeding research progress in breast and ovarian cancers. Molecular and Clinical Oncology 7:1, pages 3-14.
Crossref
Zhan Wang, Juan Chen, Mei-Zuo Zhong, Juan Huang, Yuan-Ping Hu, De-Yun Feng, Zhi-Jiao Zhou, Xiao Luo, Zhao-Qian Liu, Wu-Zhong Jiang & Wei-Bing Zhou. (2017) Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients. Cancer Chemotherapy and Pharmacology 79:3, pages 535-543.
Crossref
Irena Ranogajec. 2017. Proteases in Human Diseases. Proteases in Human Diseases 3 20 .
Ruchika Kaul-Ghanekar, Snehal Suryavanshi & Prerna Raina. 2015. Noninvasive Molecular Markers in Gynecologic Cancers. Noninvasive Molecular Markers in Gynecologic Cancers 61 142 .
Wanying Xing, Qiang Li, Rangjuan Cao & Zheli Xu. (2014) Neogenin expression is inversely associated with breast cancer grade in ex vivo. World Journal of Surgical Oncology 12:1.
Crossref
Hee-Jin Lee, Tien Cuong Dang, Hyunju Lee & Jong C. Park. (2014) OncoSearch: cancer gene search engine with literature evidence. Nucleic Acids Research 42:W1, pages W416-W421.
Crossref
Jingjuan Qiao, Shenghui Xue, Fan Pu, Natalie White, Jie Jiang, Zhi-Ren Liu & Jenny J. Yang. (2013) Molecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agents. JBIC Journal of Biological Inorganic Chemistry 19:2, pages 259-270.
Crossref
Irena Ranogajec, Jasminka Jakić-Razumović, Velibor Puzović & Jelka Gabrilovac. (2011) Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients. Medical Oncology 29:2, pages 561-569.
Crossref
Mohammad Mohammadianpanah, Yaghoub Ashouri, Sare Hoseini, Niloofar Amadloo, Abdolrasoul Talei, Sedigheh Tahmasebi, Hamid Nasrolahi, Ahmad Mosalaei, Shapour Omidvari, Mansour Ansari & Mohammad Amin Mosleh-Shirazi. (2011) The efficacy and safety of neoadjuvant chemotherapy +/− letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial. Breast Cancer Research and Treatment 132:3, pages 853-861.
Crossref
Atsuko Yoneda, Maria E. Lendorf, John R. Couchman & Hinke A. B. Multhaupt. (2011) Breast and Ovarian Cancers. Journal of Histochemistry & Cytochemistry 60:1, pages 9-21.
Crossref
Jennifer R. Choo & Torsten O. Nielsen. (2010) Biomarkers for Basal-like Breast Cancer. Cancers 2:2, pages 1040-1065.
Crossref
Yung-Lung Kuo, Chien-Chuan Ko & Jen-Yuan Lai. (2010) Automated assessment in HER-2/neu immunohistochemical expression of breast cancer. Automated assessment in HER-2/neu immunohistochemical expression of breast cancer.
H. Masmoudi, S.M. Hewitt, N. Petrick, K.J. Myers & M.A. Gavrielides. (2009) Automated Quantitative Assessment of HER-2/neu Immunohistochemical Expression in Breast Cancer. IEEE Transactions on Medical Imaging 28:6, pages 916-925.
Crossref
Jenny M. Armenta, Abdulilah A. Dawoud & Iulia M. Lazar. (2009) Microfluidic chips for protein differential expression profiling. ELECTROPHORESIS 30:7, pages 1145-1156.
Crossref
Menaka D. S. Lokuhetty, Gayani G. Ranaweera, Manarangi D. M. Wijeratne, Kumudu H. Wickramasinghe & Abdul H. Sheriffdeen. (2009) Profile of Breast Cancer in a Group of Women in a Developing Country in South Asia: Is There a Difference?. World Journal of Surgery 33:3, pages 455-459.
Crossref
Iulia M. Lazar. 2008. Miniaturization and Mass Spectrometry. Miniaturization and Mass Spectrometry 151 172 .
Bin Wang, Ning Wang, Chunyan Xue, Bin Jiang & Yajie Wang. (2008) Expression and prognostic value of plasminogen activator inhibitor type 1 in node-negative breast cancer. The Chinese-German Journal of Clinical Oncology 7:6, pages 339-343.
Crossref
Min Xu, Ming-Chih J Kao, Juan Nunez-Iglesias, Joseph R Nevins, Mike West & Xianghong Jasmine Zhou. (2008) An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer. BMC Genomics 9:S1.
Crossref
Tamara KeithVian AmberJustin Stebbing. (2007) New biomarkers in breast cancer: microRNAs and leptins – where are we now?. Biomarkers in Medicine 1:1, pages 9-11.
Crossref
Lígia R. Rodrigues, José A. Teixeira, Fernando L. Schmitt, Marie Paulsson & Helena Lindmark-Mänsson. (2007) The Role of Osteopontin in Tumor Progression and Metastasis in Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention 16:6, pages 1087-1097.
Crossref
Ming Lu, Kym F. Faull, Julian P. Whitelegge, Jianbo He, Dejun Shen, Romaine E. SaxtonHelena R. Chang. (2017) Proteomics and Mass Spectrometry for Cancer Biomarker Discovery. Biomarker Insights 2, pages 117727190700200.
Crossref
Hetal A. Sarvaiya, Jung H. Yoon & Iulia M. Lazar. (2006) Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation. Rapid Communications in Mass Spectrometry 20:20, pages 3039-3055.
Crossref
Caterina Bianco, Luigi Strizzi, Mario Mancino, Aasia Rehman, Shin Hamada, Kazuhide Watanabe, Antonella De Luca, Brenda Jones, Gabriela Balogh, Jose Russo, Daniel Mailo, Raffaele Palaia, Giuseppe D'Aiuto, Gerardo Botti, Francesco Perrone, David S. Salomon & Nicola Normanno. (2006) Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon Cancer. Clinical Cancer Research 12:17, pages 5158-5164.
Crossref
P. Therasse, S. Carbonnelle & J. Bogaerts. (2006) Clinical trials design and treatment tailoring: General principles applied to breast cancer research. Critical Reviews in Oncology/Hematology 59:2, pages 98-105.
Crossref
Mary Jo Fackler, Kara Malone, Zhe Zhang, Eric Schilling, Elizabeth Garrett-Mayer, Theresa Swift-Scanlan, Julie Lange, Ritu Nayar, Nancy E. Davidson, Seema A. Khan & Saraswati Sukumar. (2006) Quantitative Multiplex Methylation-Specific PCR Analysis Doubles Detection of Tumor Cells in Breast Ductal Fluid. Clinical Cancer Research 12:11, pages 3306-3310.
Crossref
Lajos Pusztai. 2006. Textbook of Breast Cancer. Textbook of Breast Cancer 81 100 .
P. Therasse & J. Bogaerts. 2006. Breast Cancer and Molecular Medicine. Breast Cancer and Molecular Medicine 1007 1020 .
. 2006. Fine Needle Aspiration Cytology. Fine Needle Aspiration Cytology 7 33 .
Margaret R. Spitz, Xifeng Wu & Gordon Mills. (2005) Integrative Epidemiology: From Risk Assessment to Outcome Prediction. Journal of Clinical Oncology 23:2, pages 267-275.
Crossref
Lajos Pusztai. (2004) Perspectives and challenges of clinical pharmacogenomics in cancer. Pharmacogenomics 5:5, pages 451-454.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.